isoxazoles has been researched along with Connective Tissue Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Coghlan, JG; Denton, CP; Handler, CE; Kabunga, P; Smith, CJ; Valerio, CJ | 1 |
| Barst, RJ; Frost, AE; Girgis, RE; Hill, NS; Horn, EM; Langleben, D; McLaughlin, VV; Oudiz, RJ; Robbins, IM; Seibold, JR; Shapiro, S; Tapson, VF | 1 |
1 trial(s) available for isoxazoles and Connective Tissue Diseases
| Article | Year |
|---|---|
Selective endothelin A receptor antagonism with sitaxsentan for pulmonary arterial hypertension associated with connective tissue disease.
Topics: Adolescent; Adult; Aged; Antihypertensive Agents; Blood Pressure; Cardiac Output; Connective Tissue Diseases; Dose-Response Relationship, Drug; Double-Blind Method; Endothelin A Receptor Antagonists; Female; Follow-Up Studies; Humans; Hypertension, Pulmonary; Isoxazoles; Male; Middle Aged; Quality of Life; Thiophenes; Treatment Outcome; Vascular Resistance; Walking | 2007 |
1 other study(ies) available for isoxazoles and Connective Tissue Diseases
| Article | Year |
|---|---|
Clinical experience with bosentan and sitaxentan in connective tissue disease-associated pulmonary arterial hypertension.
Topics: Aged; Antihypertensive Agents; Bosentan; Clinical Trials as Topic; Connective Tissue Diseases; Female; Humans; Hypertension, Pulmonary; Isoxazoles; Male; Middle Aged; Statistics as Topic; Sulfonamides; Thiophenes; Treatment Outcome | 2010 |